FABRAZYME subst sèche 5 mg flac
7680562610034
CH-56261
A16AB04
07.14.0.
1 / 2
google
Details
- Product number
- 5626103
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: agalsidasum beta 5 mg, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, pro vitro, natrium 1.82 mg.
Articles (1)
Fabrazyme 5 mg, poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.82 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 536.60
Specialties list
Yes
Generic
No
SL addition date:
01/10/2023
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 56261
- Drug name
- Fabrazyme, poudre pour solution à diluer pour perfusion
- Galenic form
- PULPA
- ATC Code
- A16AB04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/07/2003
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FABRAZYME subst sèche 5 mg flac
- Description (DE)
- FABRAZYME Trockensub 5 mg Durchstf
- Market launch
- 01/09/2020
- Narcotic (BTM)
- No